486 related articles for article (PubMed ID: 16951733)
1. The need for speed: an update on methamphetamine addiction.
Barr AM; Panenka WJ; MacEwan GW; Thornton AE; Lang DJ; Honer WG; Lecomte T
J Psychiatry Neurosci; 2006 Sep; 31(5):301-13. PubMed ID: 16951733
[TBL] [Abstract][Full Text] [Related]
2. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies.
Shrestha P; Katila N; Lee S; Seo JH; Jeong JH; Yook S
Biomed Pharmacother; 2022 Oct; 154():113591. PubMed ID: 36007276
[TBL] [Abstract][Full Text] [Related]
4. An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.
Jacobs E; Fujii D; Schiffman J; Bello I
Cogn Behav Neurol; 2008 Jun; 21(2):98-103. PubMed ID: 18541986
[TBL] [Abstract][Full Text] [Related]
5. Psychotic symptoms in methamphetamine psychotic in-patients.
Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M
Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.
Panenka WJ; Procyshyn RM; Lecomte T; MacEwan GW; Flynn SW; Honer WG; Barr AM
Drug Alcohol Depend; 2013 May; 129(3):167-79. PubMed ID: 23273775
[TBL] [Abstract][Full Text] [Related]
7. BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine.
Manning EE; Halberstadt AL; van den Buuse M
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26453694
[TBL] [Abstract][Full Text] [Related]
8. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
[TBL] [Abstract][Full Text] [Related]
9. Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.
Miner NB; Elmore JS; Baumann MH; Phillips TJ; Janowsky A
Neurotoxicology; 2017 Dec; 63():57-69. PubMed ID: 28919515
[TBL] [Abstract][Full Text] [Related]
10. A commentary on the effects of methamphetamine and the status of methamphetamine abuse among youths in South Korea, Japan, and China.
Kwon NJ; Han E
Forensic Sci Int; 2018 May; 286():81-85. PubMed ID: 29567545
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of methamphetamine abuse in Missouri.
Topolski JM
Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
Willi TS; Honer WG; Thornton AE; Gicas K; Procyshyn RM; Vila-Rodriguez F; Panenka WJ; Aleksic A; Leonova O; Jones AA; MacEwan GW; Barr AM
Psychiatry Res; 2016 Jun; 240():336-342. PubMed ID: 27138828
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine, neurotransmitters and neurodevelopment.
Čechová B; Šlamberová R
Physiol Res; 2021 Dec; 70(S3):S301-S315. PubMed ID: 35099249
[TBL] [Abstract][Full Text] [Related]
14. Health outcomes associated with methamphetamine use among young people: a systematic review.
Marshall BD; Werb D
Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone treatment alleviates the impairments of neurogenesis, mitochondrial biogenesis and memory performance induced by methamphetamine.
Seyedhosseini Tamijani SM; Beirami E; Ahmadiani A; Dargahi L
Neurotoxicology; 2019 Sep; 74():7-18. PubMed ID: 31075280
[TBL] [Abstract][Full Text] [Related]
16. Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure.
Beirami E; Oryan S; Seyedhosseini Tamijani SM; Ahmadiani A; Dargahi L
J Cell Biochem; 2018 Feb; 119(2):2345-2355. PubMed ID: 28884876
[TBL] [Abstract][Full Text] [Related]
17. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
Salo R; Fassbender C; Iosif AM; Ursu S; Leamon MH; Carter C
Psychiatry Res; 2013 Dec; 210(2):529-35. PubMed ID: 23896355
[TBL] [Abstract][Full Text] [Related]
18. Hostility among methamphetamine users experiencing psychotic symptoms.
McKetin R; McLaren J; Lubman DI; Hides L
Am J Addict; 2008; 17(3):235-40. PubMed ID: 18464001
[TBL] [Abstract][Full Text] [Related]
19. [In Germany difficult to come by. Crystal meth: "definitely one of the most dangerous drugs in the world"].
Oberhofer E
MMW Fortschr Med; 2014 Aug; 156(14):18-9. PubMed ID: 25195388
[No Abstract] [Full Text] [Related]
20. Long-term cognitive, emotional and neurogenic alterations induced by alcohol and methamphetamine exposure in adolescent rats.
Loxton D; Canales JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Mar; 74():1-8. PubMed ID: 27865801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]